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Estradiolge family of secreted glycoproteins that play important roles in controlling tissue
patterning, cell fate and proliferation during development. Currently, little is known regarding the role(s) of
Wnt genes during prostate gland development. The present study examines the role of the noncanonical
Wnt5a during prostate gland development in rat and murine models. In the rat prostate, Wnt5a mRNA is
expressed by distal mesenchyme during the budding stage and localizes to periductal mesenchymal cells
with an increasing proximal-to-distal gradient during branching morphogenesis. Wnt5a protein is secreted
and localizes to periductal stroma, extracellular matrix and epithelial cells in the distal ducts. While Wnt5a
expression is high during active morphogenesis in all prostate lobes, ventral prostate (VP) expression
declines rapidly following morphogenesis while dorsal (DP) and lateral lobe (LP) expression remains high
into adulthood. Steroids modulate prostatic Wnt5a expression during early development with testosterone
suppressing Wnt5a and neonatal estrogen increasing expression. In vivo and ex vivo analyses of developing
mouse and rat prostates were used to assess the functional roles of Wnt5a. Wnt5a−/− murine prostates
rescued by organ culture exhibit disturbances in bud position and directed outgrowth leading to large
bulbous sacs in place of elongating ducts. In contrast, epithelial cell proliferation, ductal elongation and
branchpoint formation are suppressed in newborn rat prostates cultured with exogenous Wnt5a protein.
While renal grafts of Wnt5a−/− murine prostates revealed that Wnt5a is not essential for cyto- and
functional differentiation, a role in luminal cell polarity and lumenization of the ducts was indicated. Wnt5a
suppresses prostatic Shh expression while Shh stimulatesWnt5a expression in a lobe-speciﬁc manner during
early development indicating that Wnt5a participates in cross-talk with other members of the gene
regulatory network that control prostate development. Although Wnt5a does not inﬂuence prostatic
expression of other Wnt morphogens, it suppresses Wif-1 expression and can thus indirectly modulate Wnt
signaling. In summary, the present ﬁnds demonstrate that Wnt5a is essential for normal prostate
development where it regulates bud outgrowth, ductal elongation, branching, cell polarity and lumenization.
These ﬁndings contribute to the growing body of knowledge on regulatory mechanisms involved in prostate
gland development which are key to understanding abnormal growth processes associated with aging.
© 2009 Elsevier Inc. All rights reserved.Introduction
The prostate is a branched exocrine secretory gland of the male
reproductive tract that originates from the endodermal urogenital
sinus (UGS). In humans, prostate gland development occurs during
the second and third trimesters of gestation, whereas in the rodent, a
commonly studied model system, budding initiates late in fetal life
and branchingmorphogenesis occurs postnatally (Hayashi et al., 1991;
Sugimura et al., 1986). At birth, the rodent prostate consists of solid
unbranched, elongating ducts extending into the ventral, lateral and
dorsal UGSmesenchyme to form the separate ventral (VP) lateral (LP)955, University of Illinois at
1 312 996 1291.
l rights reserved.and dorsal (DP) prostate lobes with lobe-speciﬁc branching patterns
(Timms et al., 1994). Mesenchymal and epithelial cell cytodifferentia-
tion with lumen formation is coordinated with branching morpho-
genesis, beginning in the proximal ducts and slowly extending
towards the distal tips between postnatal days (pnd) 10–15 (Prins
and Birch, 1995). Functional differentiation with production of
secretory proteins by differentiated luminal cells follows thereafter.
Prostate gland development is an androgen-dependent process
with the early events regulated through androgen receptors (AR) in
mesenchymal cells (Cunha and Chung, 1981; Price, 1936; Prins and
Putz, 2008). Other steroid receptors, including estrogen receptors
(ERs) and retinoid receptors (RARs and RXRs) are expressed in a cell
speciﬁc manner during early development and contribute to prostate
morphogenesis and differentiation (Prins and Birch, 1997; Prins et al.,
2002). As with all branched structures, appendicular patterning and
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common and organ-speciﬁc morphoregulatory genes that are
expressed in a unique temporal and spatial pattern. These include
transcription factors Hoxa13, Hoxb13, Hoxd13, Nkx3.1 and Foxa1 and
secreted paracrine factors Fgf10, Shh, Tgfβ1 and Bmp 4 and 7 {see
recent review (Prins & Putz, 2008)}. Several of these developmental
genes, cognate receptors and/or downstream signaling molecules are
regulated at some level by the various steroids to effect hormone
regulated development, although this process is not completely
understood. In other branched organs such as the lung, kidney, and
mammary gland, theWnt gene family plays critical roles in branching
morphogenesis and cell differentiation (Buhler et al., 1993; Gavin and
McMahon, 1992; Mucenski et al., 2003; Okubo and Hogan, 2004; Shu
et al., 2002; Stark et al., 1994; Yamaguchi et al., 1999). Despite a large
number of studies that have demonstrated a role for aberrant Wnt
signaling during prostate carcinogenesis and progression (Chesire and
Isaacs, 2003; Yardy and Brewster, 2005), there is little published work
on the role(s) of Wnt genes during prostate gland development.
TheWnt genes encode a large, highly conserved family of secreted
glycoproteins that play essential roles in controlling tissue patterning,
cell fate and proliferation from Drosophila to humans (Cadigan and
Nusse, 1997; Nelson and Nusse, 2004). There are 19 mammalian Wnt
proteins identiﬁed and all bind to frizzled (Fzd) cell surface receptors
to initiate cellular responses (Cadigan and Nusse, 1997). Vertebrate
Wnts have been divided into two functional groups by reference to
their downstream signaling pathways (Moon et al., 1997). In short, the
canonical Wnts signal through nuclear β-catenin/Tcf-Lef while the
noncanonicalWnts function through alternate signaling cascades that
include Ca++/PKC, RhoA/JNK or RhoB/Rab4 (Bejsovec, 2005; Witze
et al., 2008). In addition to secreted Wnt glycoproteins, the Wnt
signaling network also includes several extracellular secreted reg-
ulators that antagonize Wnt actions including secreted frizzled-
related proteins (Sfrps), Wnt inhibitory factors (Wif), and the dick-
kopf (Dkk) proteins which speciﬁcally block canonical Wnt signaling
(Hsieh et al., 1999; Mao et al., 2001).
Evidence thatWnt signaling is involved in prostate morphogenesis
comes from studies analyzing the secreted regulators Sfrp 1 and 2 and
Dkk1 and 2 whose expression rapidly declines postnatally (Pritchard
and Nelson, 2008; Zhang et al., 2006). Addition of recombinant Sfrp1
to rat VP explant cultures increased their growth over 5 days
indicating that Wnts normally inhibit this process (Joesting et al.,
2005). Further studies with Sfrp1 transgenic overexpressing and null
mutant mice conﬁrmed that this Wnt modulator stimulates prostate
branching morphogenesis, epithelial cell proliferation and secretory
gene expression (Joesting et al., 2008). Studies from our laboratory
showed that Dkk1 protein also stimulated growth and branching of
cultured newborn rat VP lobes over a four-day period suggesting that
canonicalWnts suppress prostate growth (Prins and Putz, 2008). This
is supported by another recent study where Wnt3a, a canonical Wnt,
reduced ductal branching of cultured neonatal mouse prostates and
active canonical Wnt signaling in epithelial progenitor cells main-
tained their undifferentiated state (Wang et al., 2008). To determine
which Wnt genes are actively involved in prostate development, we
recently screened rat prostates for Wnt gene expression during early
development and identiﬁed robust expression of the canonical Wnt2,
Wnt2b and Wnt7b genes and the non-canonical Wnt4, Wnt5a and
Wnt11 genes. In the present study, we examined in detail the role of
Wnt5a in prostate gland development.
Wnt5a is a noncanonical Wnt ligand involved in outgrowth of
multiple structures during vertebrate development. Targeted deletion
of Wnt5a−/− in mice resulted in perinatal lethality demonstrating a
critical role for normal development of structures necessary for life
(Yamaguchi et al., 1999). Severemorphological defects observed at the
end of gestation include caudal truncation, shortening of limbs along
the proximal–distal axis, truncated trachea, overexpansion of the
distal airways, absence of the genital tubercle and lack of distalelements in affected structures (Li et al., 2002; Yamaguchi et al., 1999).
Together, these phenotypes indicate an essential role for Wnt5a in
outgrowth and patterning along the proximal–distal axis. In the
current study, we used rats and mice to identify the spatio-temporal
expression pattern ofWnt5a during prostate development, to examine
its regulation by steroid hormones and to determine its role in
budding, ductal outgrowth, branching morphogenesis and cell
differentiation. Our results reveal high levels of Wnt5a expression at
the distal tips and along the centro-distal periductal mesenchyme
during the period of postnatal branching morphogenesis with a rapid
decline thereafter in the VP but not the DP and LP. Wnt5a expression
in the newborn prostate is suppressed by testosterone and stimulated
by early exposure to estradiol. We provide evidence that Wnt5a is
involved in determining bud position and size, regulating epithelial
cell proliferation and inhibiting ductal outgrowth and branching
during prostatic development. Our ﬁndings further suggest an
essential role for thisWnt ligand in cell polarity and lumen formation
within the prostate epithelial ducts.
Materials and methods
Animals
All animals were handled according to the principles and
procedures of the Guiding Principles for the Care and Use of Animal
Research and the experiments were approved by the Institutional
Animal Care Committee. Timed pregnant female Sprague–Dawley rats
from Zivic-Miller (Pittsburgh, PA)weremonitored for delivery and the
day of birth was designated as day 0. The rats were sacriﬁced by
decapitation on postnatal day (pnd) 1, 3, 6, 10, 30 or 90, the urogenital
sinus (UGS)-prostate complexes were removed and the separate
prostate lobes were microdissected at 4 °C and either frozen in liquid
nitrogen or ﬁxed for histology. To examine the effect of developmental
estrogen exposure, male pups were treated on pnd 0, 3 and 5 with
subcutaneous injections of either 25 μg 17β-estradiol-3-benzoate
(Sigma-Aldrich Chemical Co., St. Louis, MO) in 25 μl peanut oil or with
oil alone as controls.
Wnt5a−/− null mutant mice on a C57BL/6 background were
generated as previously described (Yamaguchi et al., 1999). Hetero-
zygote breeders were housed together and the day of vaginal plug was
considered gestation day 0.5. Pregnant mothers were anesthetized at
gestation day 16.5 (e16.5) or e18.5 and the embryos removed. The
UGS with rudimentary prostates were dissected from male pups and
immediately used for organ culture or renal graft studies. TheWnt5a−/−
embryos were identiﬁed visually by a reduced size phenotype and
conﬁrmed by PCR while theWnt5a+/− andWnt5a+/+ embryos were
distinguished solely by PCR as described (Yamaguchi et al., 1999).
Prostate organ culture and imaging
To examine the effect of Wnt5a on normal rat prostate develop-
ment, rudimentary ventral prostate lobes (VP) were removed on pnd
0 (within 4 h of birth) and paired, contralateral lobes from a single pup
(n=6)were cultured for 6 days in either basal culturemedium(BOCM)
with 1.0 μg/mlmurineWnt5a protein (R&D system) or 1.0 μg/ml BSA as
controls. The BOCM consisted of DMEM/F-12 (Invitrogen/GIBCO,
Carlsbad, CA), 50 μg/ml Gentamycin, 1× insulin-transferrin-selenium
and 10 nM testosterone and was replaced every 48–72 h. Tissues were
ﬂoated on Millicell-CM ﬁlters (Millipore Corp., Bedford, MA) in 2 ml
medium in BD Falcon 12-well plates (BD Biosciences, San Jose, CA)
inside a closed culture chamber at 37 °C with ports for introduction
and exhaust of humidiﬁed 5% CO2 (Carl Zeiss MicroImaging, Inc.,
Thornwood, NY). The culture chamber was placed within a heated
incubator attached to a Zeiss Axiovert 200 inverted microscope with
an automated X–Y–Z stage and Axiocam HRm digital camera.
Movement of the automated stage to photograph each cultured
Table 1
Primers and dual-labeled probes used for real-time PCR
Gene Sequence Amplicon size (bp)
Wnt2




















Forward primer tcgctggataaaggcatcatgg 148
Reverse primer tgacaatcacattcacttcaaatgc
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AxioVision 2.0.5 and Zeiss Imaging 25A software. Digital photo-
graphs of each sample were captured at 30 minute intervals. To
generate time-lapse imaging, still images taken over the ﬁrst 72 h
were converted to a QuickTime format using QuickTime Pro.
Morphometry was performed on images taken at 10 hours intervals
from 0 to 70 h. A color-coded skeleton that denoted branching
events over time was produced with AxioVision software. The
number and length of segments for each branch generation, the total
ductal length, the number of branchpoints and total tip number
were measured. To classify branching events as terminal bifed, trifed
or lateral, additional images between the 10 h time points were
examined. Data were analyzed by analysis of variance followed by
Bonferroni post-hoc tests (Instat ver 3.01, GraphPad Software, Inc.,
San Diego, CA), using 6–10 samples for each treatment group.
To determine the effect of exogenous Wnt5a protein on rat
prostate gene expression, 8 paired VPs were cultured as above and
processed for RNA analysis after 18 h. To examine the effect of
testosterone on Wnt5a expression, 8 paired VPs were cultured in
BOCM with or without 10 nM testosterone and collected after 18 h
exposure.
The UGS complexes from Wnt5a−/− mice and wild-type litter-
mates were collected on 16.5 and cultured for 4 days in BOCM
containing 10 nM dihydrotestosterone (DHT) in place of testosterone.
The cultured tissue was collected and ﬁxed in 10% buffered
formaldehyde, parafﬁn embedded and processed for histology
examination.
Renal grafting
The UGS-prostate complexes from e16.5Wnt5a−/− and wild-type
mice were grafted under the renal capsule of 7–8 week old male nude
mice as described (http://mammary.nih.gov/tools/mousework/
Cunha001/index.html). Wild-type and mutant tissues were grafted
to contralateral kidneys of recipient mice which were supplemented
with subcutaneous 0.5 cm sialastic capsules ﬁlled with crystalline
testosterone. After 30 days, the kidneys were removed and grafts were
cut out en masse and either ﬁxed in 10% buffered formaldehyde or
directly processed for RNA extraction. A small piece of graft tissue was
taken before ﬁxation and used for genotyping.
Immunohistochemistry (IHC)
Wnt5a, p63, cytokeratins 8/18 (CK8/18), e-cadherin, AR and
secretory DLP protein were localized by IHC in ﬁxed, dehydrated
and parafﬁn-embedded tissues as previously described (Prins and
Birch, 1995; Putz et al., 2001). For Wnt5a, tissues were frozen in
Tissue-Tek O.C.T. compound (Sakura Finetek, USA, Inc., Torrence, CA)
and frozen sections were ﬁxed in 2% paraformaldehyde. All sections
were blocked with Superblock (Vector laboratories, Inc., Burlingame,
CA) and incubated overnight at 4 °C with goat anti-mouse Wnt5a
antibody (10 μg/ml, R&D system, Minneapolis, MN), rabbit anti-p63
antibody (1:500, sc-8343; Santa Cruz), guinea pig anti-CK8/18
(American Research Products 03-GP11, Belmont, MA), 50 μg/ml
mouse anti-E-cadherin (Transduction Laboratories,Lexington, KY),
5 μg/ml rabbit anti-AR (PG-21) (Prins et al., 1991) or rabbit anti-
mouse DLP antibody (kindly provide by Dr. AnneMarie Donjacour).
The sections were reacted with biotinylated anti-IgG (Vector
Laboratories, Inc.) and detected with avidin–biotin peroxidase (ABC-
Elite Vector Laboratories) using diaminobenzidine tetrachloride
(DAB) as chromagen. For controls, normal goat, rabbit, guinea pig or
mouse IgG was substituted for primary antibody. The sections were
counterstained with Gill's #3 hematoxylin (1:4).
To localize BrdU-labeled cells from organ culture studies, the
tissues were pulsed with 10 μM BrdU (Sigma-Aldrich) 2 h prior to
culture termination and BrdU was detected by IHC as previouslydescribed (Huang et al., 2005). For statistical comparisons, BrdU
labeling was analyzed by two-tailed Student's t-test.
Whole mount in situ hybridization (wmISH)
The rat Wnt5a plasmid was kindly provided by Dr. Yiming Zhu at
the University of Chicago. The plasmid was linearized by Hind III and a
802 bp anti-sense digoxigenin-labeled RNA probe was prepared by in
vitro transcription with T7 RNA polymerase (Roche). WmISH was
performed as previously described (Huang et al., 2005) using 0.2 μg/
ml digoxigenin-labeled RNA probe. Following overnight incubation
with anti-digoxygenin alkaline phosphatase-conjugated antiserum
(Roche, Indianapolis, IN), the samples were color reacted with NBT
and BCIP (Roche). Pnd 1, 3, 6 prostatic complexes were processed
together within each assay to permit direct comparisons of signal
intensity for temporal analysis. Six separate wmISH assays were
performed on neonatal rats treated neonatally with oil or estradiol. To
identify cellular localization of gene expression, wmISH-stained
tissues were cross-sectioned at 10 μm.
Real-time RT-PCR
Real-time RT-PCR was performed using our published sequences
for primers and probes for Wnt5a, Shh, Ptc, Fgf10, Nkx3.1, Hoxb13,
Bmp4 and Rpl19 (Huang et al., 2005; Pu et al., 2004, 2007). The exon-
spanning primers and dual-labeled probes forWnts 2, 2b, 4, 7b, 11 and
Wif1 are listed in Table 1. Primers were designed across exon
boundaries to minimize the effect of potential genomic DNA
contamination. The primers and dual-labeled probes were designed
on the Primer3 website (http://www-genome.wi.mit.edu/cgi-bin/
primer/primer3_www.cgi) and secondary structure was avoided
when possible. The melting temperature (Tm) of primers was 58–
60 °C and the Tm of dual-labeled probes was 68–70 °C. For dual-
labeled probes, 5′ reporters were FAM for Shh, Ptc, Fgf10, Hoxb13,
Bmp4, Wnt2, Wnt2b, Wnt4, Wnt5a, Wnt7b and Wnt11 and Hex for
Rpl19. For Nkx3.1 and Wif1, a SYBR green assay with melting curve
was used to ensure no nonspeciﬁc ampliﬁcation. For all genes,
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cloning kit (Invitrogen) and used for standard curves, which were run
in parallel for each reaction. The actual amount of target DNA in each
experimental sample was directly calculated from each plasmid DNA
standard curve. Ribosomal protein L19 (Rpl19) was quantitated and
served as an internal reference gene for normalization. Under these
conditions, it was determined that as low as 100 gene copies in a
single neonatal prostate lobe could be reliably measured.
Total RNA was extracted with RNeasy (Qiagen, Valencia, CA) and
reverse transcribed with iScript cDNA Synthesis Kit (Bio-Rad,
Hercules, CA). Quantitative real-time PCR was performed as pre-
viously described (Huang et al., 2005; Pu et al., 2004) using an iCycler
(Bio-Rad). Each data point was repeated 3–15 times with prostate
tissue from different animals. The ratio of Amplicon cDNA copy
number of a speciﬁc gene to Rpl19 was calculated, and statistical
analysis was performedwith two-tailed Student's t test or for multiple
comparisons, analysis of variance followed by Bonferroni post-hoc
analysis. Pb0.05 was considered as statistically signiﬁcant.
Results
Ontogeny and localization of Wnt5a in the developing rat prostate gland
The temporal and spatial pattern of Wnt5a expression was
followed in individual lobes during rat prostate development.
Expression levels of Wnt5a mRNA in the VP were high between pnd
1–10, rapidly decreased by day 15 and slowly decline thereafter to aFig. 1. (A) Ontogeny of Wnt5a mRNA expression in the rat ventral prostate lobes as
quantiﬁed by real-time RT-PCR. Wnt5a expression in the VP was high at birth and
remained at high level until pnd 10. The expression level markedly declined thereafter
reaching a nadir in young adulthood. Each point represents mean±SEM for 3-9
replicates. ⁎Pb0.05 vs. pnd 1, ⁎⁎Pb0.01 vs. pnd 1, #Pb0.05 vs. pnd 3, ##Pb0.01 vs. pnd 3,
###Pb0.001 vs. pnd 3, +Pb0.05 vs. day 6, aPb0.05 vs. pnd 10. (B) Wnt5a expression
levels in the lateral and dorsal prostate are comparable to ventral prostate expression
levels during the early developmental stage. Each point represents the mean±SEM for
3–11 replicates. ⁎Pb0.05 vs. pnd 6, ⁎⁎⁎Pb0.001 vs. pnd 6.nadir at day 90 (Fig. 1). Expression was also high in DP and LP lobes
during early development (Fig. 1) but in contrast to the VP, did not
decline into adulthood (data not shown). During morphogenesis,
Wnt5a mRNA localized intensely to the condensed mesenchymal cells
surrounding the central-to-distal aspects of the elongating and
branching ducts with the most intense signal observed at the distal
ductal tips (Figs. 2A–E). Signal intensity was sustained between pnd
1–6 and was similar between the separate prostate lobes which
corroborates the quantitative RT-PCR results. Cross-sectional analysis
of the pnd 3 VP from the wmISH conﬁrmed that Wnt5a mRNA was
limited to the periductal mesenchymal cells with no signal observed
in the epithelium (Fig. 2E). In contrast, Wnt5a protein localized to
periductal mesenchymal cells, the extracellular matrix and epithelial
cells in the distal ductal regions documenting its secretion by stromal
cells (Figs. 2G, H). Wnt5a protein association with epithelial cells was
largely conﬁned to the distal ducts as proximal epithelial cells were
mostly negative for Wnt5a (Figs. 2I, J).
Role of Wnt5a in prostate growth and branching morphogenesis
An organ culture system that recapitulates prostate morphogen-
esis was used to examine the effects of Wnt5a protein on prostate
growth and branching. While culture of newborn rat VPs for 6 days in
testosterone resulted in morphogenesis of a complex branched ductal
system, addition of Wnt5a markedly inhibited ductal outgrowth and
branching (Fig. 3A). Distal tip numbers in images taken at day 6 were
reduced from 58±4 in control VPs to 11±2 in lobes cultured in
Wnt5a (Fig. 3B). Epithelial cell proliferation, as assessed by BrdU
labeling, was signiﬁcantly suppressed in the central–distal ducts (Figs.
3C, D) but not in the proximal ducts. Apoptosis, as examined by TUNEL
labeling, was rarely observed at pnd 6 in the presence or absence of
Wnt5a (data not shown).
The suppressive effects of Wnt5a on prostatic branching patterns
were assessed by real-time imaging. Quick-time movies of contra-
lateral VP lobes simultaneously cultured in the presence of 1 μg/ml
BSA or Wnt5a protein for 72 h are shown in Suppl. Fig. 1. While
outgrowth of the original ducts with sequential branching of multiple
ductal generations was observed in control lobes, ductal elongation
and branchpoint formation were markedly reduced byWnt5a. Kinetic
analysis was performed on color-coded skeletonized images (Suppl.
Fig. 2). The initial buds that evaginated from the UGS into the VP
mesenchymal pad were classiﬁed as “original ducts” (4 per VP lobe).
The branches that formed by terminal bud division or lateral branches
off the original duct were considered “ﬁrst generation”, branches off
the ﬁrst generation ducts were considered “second” generation and so
forth. Frequently, the original ducts had begun to branch at the time of
birth and ﬁrst generation ducts were present. During the ﬁrst 72 h of
culture, ﬁve branch generations developed in control VPs. Each
generation progressively elongated (Fig. 4A) and produced branch-
points at regular intervals (Fig. 4B) to create similar sized segments
throughout the tissue. Branchpoint patterns included terminal bifeds
(51%), terminal trifeds (13%) and lateral side branches (36%) resulting
in a complex branched network (Suppl. Fig. 3A). Exogenous Wnt5a
protein markedly reduced ductal elongation (Fig. 4A) and branching
events over time (Fig. 4B) with only three branch generations forming
over the 72 h period. While the total tip number was markedly
reduced as early as 20 h after exposure toWnt5a (Suppl. Fig. 3B), the
pattern of branch point events was not altered (Suppl. Fig. 3A).
Null mutantWnt5a−/−mice were used to assess the loss ofWnt5a
expression on prostate morphogenesis. Since Wnt5a−/− mice are
perinatal lethal, the UGS complex was dissected from e16.5 mice and
cultured to examine the role of Wnt5a during the early stages of
prostate development. It should be noted that the mouse prostate is
less well developed than the rat prostate (Price, 1963) and forms only
secondary with some tertiary branchpoints in vivo at pnd 15 and
minimal branching after 6 days in vitro. After 4 days of culture with
Fig. 2. Localization of Wnt5a transcript (A–E) and Wnt5a protein (F, G) in the developing rat prostate gland. Wnt5a mRNA expression was examined by wmISH and exhibited a
periductal pattern typical formesenchyme-expressed genes. To allowdirect comparisons of signal strength, tissues frompnd 1 (A), pnd 3 (B, C) and pnd 6 (D)were processed together.
Wnt5amRNA expression localized to periductal cells along the ductal lengthwith an increasing gradient from the proximal duct out towards the distal tips where the signal wasmost
intense. (E) Cross-section of pnd 3VP fromwmISH conﬁrms strongWnt5a expression in themesenchymal cells (m) immediately adjacent to the ducts but not in the epithelial cells (e).
Wnt5a proteinwas localized by immunohistochemistry in pnd 6 VP tissue sections counterstainedwith hematoxylin. (F) Negative control IgG in place ofWnt5a on an adjacent section
shows lack of signal in the mesenchymal and epithelial cells. (G, H) Low and higher power images, respectively, of Wnt5a protein localized to mesenchymal cells and extracellular
matrix (arrows) and to the cell surface of epithelial (e) cells (arrowheads) in the distal VP ducts. (I–J) Wnt5a protein immunostain in the proximal VP ducts was strong in periductal
mesenchyme (arrows) but negligible in the epithelium. Scale bars: A–D=200 μm; E–F, G, I=50 μm; H and J=20 μm. VP = ventral prostate, DP = dorsal prostate, LP1 = lateral
prostate type 1 ducts, LP2 = lateral prostate type 2 ducts.
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elongating from the UGS in the ventral, lateral and dorsal directions in
the Wnt5a+/+ mice with equivalent widths and even spacing
between the emerging ducts (Fig. 5). In sharp contrast, epithelial
projections in the Wnt5a−/− UGS were disorganized in position and
consisted of large bulbous outgrowths intermingled with short buds
projecting in a seemingly random manner (Fig. 5). The failure of
Wnt5a−/− prostates to establish orderly growth suggests a critical role
for Wnt5a in organizing bud position and controlling proper out-growth and movement of cells along a proximal-to-distal axis.
Heterozygote and wild-type pups maintained through pnd 30 had
similar prostateweights and distal tip numbers indicating noWnt5a+/−
haplotype for the prostate gland.
Role of Wnt5a in prostate cell differentiation
Newborn rat VPs cultured in the absence or presence of exogenous
Wnt5a protein were examined with cell differentiation markers. After
Fig. 3. Cultured rat VP following addition of BSA (controls) or Wnt5a protein. Paired
lobes from a single rat were treated with either BSA or Wnt5a (1.0 μg/ml) to permit
direct comparison of Wnt5a treatment. (A) VP collected on pnd 0 and after culture for
6 days in BOCMwith either BSA orWnt5a protein.Wnt5a markedly inhibited the ductal
outgrowth and branching. Bar=500 μM. (B) Number of distal tips observed in 2-D
photographs of VPs taken after 6 day culture with or withoutWnt5a. Bars represent the
mean±SEM. ⁎⁎⁎Pb0.0001 versus BSA (n=5). (C) VPs were labeled with BrdU after 6-
day culture in BSA or Wnt5a. The number of proliferating epithelial cells was greatly
reduced in the central–distal epithelial ducts of Wnt5a-treated prostates as compared
to BSA controls. (D) BrdU labeling index of epithelial cells in the proximal and central–
distal regions of VP lobes cultured for 6 days with or withoutWnt5a. The bar represents
the mean±SEM of 4 replicates. ⁎⁎Pb0.05 versus BSA.
Fig. 4. Kinetics of prostatic bud elongation and branching in newborn rat contralateral
VPs exposed to BSA (controls) or Wnt5a protein (1 μg/ml) for 72 h. (A) Aggregate
length (μM) of all ductal segments in each successive branch generation over time. Solid
lines represent data from control VPs and dotted lines represent data from Wnt5a-
exposed VPs. (B) Total number of branchpoint events in each ductal generation as a
function of time. Solid lines represent data from control VPs and dotted lines represent
data from Wnt5a-exposed VPs. Error bars denote SEM from 6 sets of experiments.
Differences between the two treatments were statistically signiﬁcant (Pb0.05) from
20 h onward for both data sets.
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along the proximal-to-distal axis as described (Jarred et al., 2000;
Prins and Birch, 1995). Proximal ducts had begun to canalize and
contained a continuous layer of basal epithelial cells (p63+) under-
neath a layer of short columnar luminal cells (CK8/18+). The luminal
cells exhibited basal–apical polarization as highlighted by lateral
surface e-cadherin stain (Fig. 6). A multi-cell layer of smooth muscle
cells (α-actin+) surrounded the proximal ducts. In the distal aspects
of the branched ducts, differentiation was less advanced. Basal cells
(p63+) lined the solid epithelial cords ﬁlled with p63+ and CK8/18+
cells that were polarized to form a pinwheel-shaped pattern (see e-
cadherin stain). Although periductal mesenchyme occasionally
stained for α-actin (Fig. 6, arrows), most cells were negative for
markers of smooth muscle differentiation. Rat VPs cultured for 6 days
with exogenous Wnt5a protein exhibited signs of delayed maturation
and cell differentiation. While proximal duct epithelial cells were
similar to control prostates, the periductal mesenchyme showed no
evidence of smooth muscle cell differentiation. In the distal ducts, the
enlarged ductal tips were ﬁlled with p63+ basal cells with minimalCK8/18+ signal. Pockets of epithelial cells were negative for e-
cadherin (Fig. 6, arrow) and the cells that stained for e-cadherin
showed a lack of basal–apical alignment. Themesenchymal cells in the
distal ducts exhibited no signs of differentiation in the presence of
exogenousWnt5a.
Since the prostate has a limited capacity to fully differentiate in
vitro, the role of Wnt5a on prostate maturation and functional
differentiation was examined in Wnt5a−/− mouse prostates that
were rescued by renal grafts for 4weeks. Loss of prostaticWnt5adidnot
interfere with the capacity of the epithelial cells to fully cytodiffer-
entiate and express secretory proteins as evidenced by the presence of
intermittent p63+ basal cells along the basement membrane, luminal
columnar epithelial cells (CK8/18+) and strong immunostain for DLP
protein in dorsolateral lobes of mutant mice which was similar to
wild-type prostates (Fig. 7). Further, there was no difference in
proliferation or apoptosis rates or in AR immunostain between the
Fig. 5. Wnt5a+/+ (WT) and Wnt5a−/− mouse UGS-prostatic complex collected on e16.5 and cultured for 4 days in basal medium with 10−8 M dihydrotestosterone. (A) The UGS
fromwild-typemouse (left) developednumerous and symmetric elongating buds in thedorsal (DP), lateral (LP) andventral (VP) regions. In contrast, epithelial buds from theWnt5a−/−
UGS (right) were nonsymmetrical in position, widely varied in size from bulbous (arrowheads) to small buds (arrow) which failed to elongate. Bar=500 μM. (B) Eosin-stained cross
sections of cultured prostatic tissue show numerous prostatic ducts of similar diameter in the wild-type (WT) tissue and irregular bud size and position in tissue from homozygous
Wnt5a−/−mice. Blue circles outline the epithelial buds. Bar=50 μM.
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However, Wnt5a−/− prostate grafts consistently exhibited defective
lumenization of epithelial ducts with apparent loss of luminal cell
polarity. In wild-type prostates, acini contained a single cell layer of
cuboidal-columnar luminal cells oriented in a basal–apical manner
with basally located nuclei, lateral e-cadherin stain and open lumens
containing secretions. In contrast, ducts of Wnt5a−/− prostate grafts
were typically ﬁlled with piled luminal cells that lacked appropriate
orientation as visualized by nuclei positioned centrally and apically
and e-cadherin stain encircling the piled cells (Fig. 7). Lumen
formation either failed to occur or appeared arrested at an early
stage of development typically observed at days 5–10 of postnatal
life (Fig. 7, arrowheads). In total, these ﬁndings suggest that while
Wnt5a does not permanently affect terminal differentiation, it
plays a role in controlling prostate epithelial cell proliferation,
organization and polarization.
Effects of Wnt5a on prostatic morphoregulatory genes
Previous studies have identiﬁed a complex regulatory network
between developmental genes involved in prostate morphogenesis
(Prins and Putz, 2008). Since Wnt5a has been shown to affect the
expression of multiple secreted morphogens in other developing
structures (Li et al., 2002, 2005; Mericskay et al., 2004), the effects of
Wnt5a addition or deletion on expression of several prostatic
developmental genes were assessed. To evaluate direct effects of
Wnt5a on prostate gene expression prior tomarked changes in growth
(Pu et al., 2007), organ cultures of pnd 0 rat VP lobes with or without
Wnt5a protein were terminated after 18 h and gene expression in
individual lobes was determined. As shown in Fig. 8A, Wnt5a did not
alter expression of Fgf10, Bmp4,Nkx3.1,Hoxb13 or ptc, the Shh receptor,
but did have a small yet signiﬁcant suppressive effect on prostatic Shh
mRNA levels. Since Shh has previously been shown to up-regulate
prostatic Bmp4 and down-regulate Fgf10 expression (Pu et al., 2007),
the effect of Shh protein on Wnt5a expression was examined in
contralateral VP and LP cultures. While Shh had no effect on VPWnt5amRNA levels, Wnt5a was signiﬁcantly up-regulated by Shh in the LP
lobes indicating lobe speciﬁcity in this regulatory network (Fig. 8B).
Testosterone produced a small suppressive effect on Wnt5a mRNA
levels in both the VP and LP lobes after 18 h of exposure (Fig. 8B). To
determine if Wnt5a autoregulates its own expression or affects the
expression of other Wnt genes during prostate development, their
expression was examined after 18 h of culture in exogenous Wnt5a.
While no change was observed in mRNA levels of anyWnts, there was
a signiﬁcant down-regulation of Wif1, a secreted antagonist of
canonical and noncanonical Wnts (Fig. 8C). The effect of Wnt5a
knock out on gene expressionwas examined in mouseWnt5a+/+ and
Wnt5a−/− UGS/prostates collected on e18.5 and cultured for 4 days.
Loss ofWnt5a resulted in increased Shh andWnt2b; however, this was
not statistically signiﬁcant due to high variability in Wnt5a−/−
specimens as a function of disturbed growth. Nonetheless, these
ﬁndings support the observations in the rat VP cultures whereWnt5a
protein had minimal effects on most developmental genes and only
modest down-regulation of Shh levels.
Neonatal estradiol up-regulates prostatic Wnt5a expression
Detailed previous studies in our laboratory have examined the
effects of early estradiol exposures on prostate gland morphogenesis
and shown that high-doses lead to reduced growth, abnormal
development and onset of severe prostatic dysplasia with aging
(Prins, 1992, 1997). This is mediated through early shifts in steroid
receptor expression including down-regulation of AR and up-
regulation of ERα (Prins, 1992; Prins and Birch, 1995, 1997). Down-
stream effects of altered steroidal regulation include lobe-speciﬁc
changes in expression of key developmental genes including Shh,
Fgf10, Bmp4, Nkx3.1 and Hoxb13 (Huang et al., 2004, 2005; Prins et
al., 2006; Pu et al., 2004). In the present studies, estradiol exposure on
pnd 0, 2 and 4 resulted in an immediate and signiﬁcant increase in
mesenchymal Wnt5a mRNA and protein in all three prostate lobes
which was sustained through adulthood in the VP (Figs. 9A–C). This
increased Wnt5a expression may contribute to the estrogen-induced
Fig. 6. Immunohistochemistry for p63 (basal cell marker), CK8/18 (luminal cell marker), e-cadherin, and α-actin (smooth muscle cell marker) in proximal and distal regions of rat
VPs cultured for 6 days with BSA orWnt5a protein. The proximal prostatic ducts contained a bilayer of epithelial cells in both treatment groups with basal cells (p63+) situated along
the basement membrane and differentiating luminal cells positioned above them (apical CK8/18+ stain). Strong e-cadherin stain is observed along the lateral edges of all epithelial
cells, producing a pinwheel pattern in the polarized epithelium.While lumen formationwas observed in most proximal ducts of BSA-cultured VPs, those treated withWnt5a showed
exhibited limited lumenization. Strong α-actin staining was observed in proximal periductal cells of BSA control VPs indicating their differentiation to smooth muscle cells. This
mesenchymal cell differentiation had not occurred by day 6 in the prostates cultured withWnt5a. In the distal region of BSA-cultured prostates, the solid ducts were nonlumenized
but showed appropriate organization and early differentiation with a continuous, single cell layer of p63+ basal cells along the basement membrane, light CK8/18 staining in the
central cells. In contrast, the solid epithelial cords in the distal VPs cultured with Wnt5a were largely ﬁlled with p63+ basal cells interspersed with CK8/18+ cells and many e-
cadherin negative cells (arrows) suggesting altered differentiation and inappropriate epithelial polarization. While early evidence of mesenchymal differentiation to smooth muscle
cells was observed by α-actin staining in distal BSA-treated VPs (arrows), this had not occurred in Wnt5a-treated prostates. Scale bar=50 μm.
Fig. 7. Renal grafts of Wnt5a+/+ (top row) and Wnt5a−/− knockout (bottom row) mouse prostates. The UGS/prostate complex was removed at e16.5 and grafted under the renal
capsule of nude mice for 30 days. Tissues were sectioned and stained with H&E or immunostained for p63 (basal cell marker), CK8/18 (luminal cell marker), secretory DLP protein
and e-cadherin. Arrows point to arrested lumen formation observed throughout sections of mutantWnt5a−/− prostates. Photos of H&E stain, p63, CK8/18 and e-cadherin are from
the VP while DLP protein IHC was taken of DLP regions of the graft. Scale bar=50 μM.
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Fig. 8. Effect ofWnt5a addition or loss on prostatic gene expression. (A–C) Gene expression in newborn rat VP lobes after 18 h organ culture as measured by real-time RT-PCR. (A)
Effect of 1 μg/mlWnt5a protein on expression of multiple developmental genes. Bars represent mean±SEM for 15 replicates. ⁎Pb0.05 BSA vs.Wnt5a protein. (B) Left: Effect of 2 μg/
ml Shh protein on Wnt5a expression in the rat VP and LP after 18 h of culture. Shh increased Wnt5a expression in LP but not VP as compared to BSA controls. Bars represent the
mean±SEM for 8 samples. ⁎⁎Pb0.01 Shh vs. BSA. Right: Effect of 10 nM testosterone on Wnt5a expression in the rat VP and LP after 18 h culture. Testosterone modestly
suppressed Wnt5a gene expression in both lobes. Bars represent the mean±SEM for 8 samples. ⁎⁎Pb0.05 −T vs. +T. (C) Effect of 1 μg/ml Wnt5a protein on expression of Wnt
genes and WIF1 in rat VP. Bars represent mean±SEM for 15 replicates. ⁎⁎Pb0.001 BSA vs. Wnt5a protein. (D) Expression of Shh, Fgf10, Wnt2b, Wnt4, Wnt5a, Wnt11 and WIF1
mRNA in wild type and Wnt5a−/− knockout mouse UGS/prostate tissues after 4 days of culture. Bars represent mean±SEM for 6 replicates.
196 L. Huang et al. / Developmental Biology 328 (2009) 188–199hypomorphogenesis observed in these tissues. Since elevations in
Wnt5a expression have been associated with several malignancies,
including prostate cancer (Iozzo et al., 1995; Liu et al., 2008; Yu et al.,
2007; Zuidervaart et al., 2007), the elevated Wnt5a in estrogenized
prostates may also contribute to the severe dysplasia observed in
neonatal estrogenized prostates.
Discussion
Wnt5a is expressed by distal periductal mesenchymal cells and interacts
with distal epithelial cells
The present studies establish an important role for the noncano-
nical Wnt5a during prostate gland development. Wnt5a is expressed
by prostatic periductal mesenchymal cells with focally intense
expression at the distal tips. This pattern is similar to distal Wnt5a
localization in other developing structures. However, unlike in lungs
whereWnt5a is expressed by distal epithelium as well as stroma (Li et
al., 2002) and uterus where low but detectableWnt5a is expressed in
epithelium in addition to abundant stromal levels (Mericskay et al.,
2004), prostate Wnt5a gene expression is restricted to mesenchymal
cells. Clear evidence for Wnt5a secretion and paracrine interaction
with epithelial cells is provided by IHC which localizesWnt5a protein
to the periductal mesenchymal cells, extracellular matrix and to
epithelial cells in the distal ducts. Thus it appears that Wnt5a is
another component of the previously described distal signaling center
in the developing prostate where active growth and branching occur
through the coordinated actions of a morphoregulatory gene signaling
network (Huang et al., 2005; Prins and Putz, 2008).
Role of Wnt5a in prostate duct outgrowth, branching, and epithelial
proliferation
Ex vivo and in vivo studies with rat and mouse prostates
demonstrate that, similar to its role in other body structures, Wnt5a
plays an essential role in prostate duct outgrowth and patterning
along the proximal–distal axis. The bud initiation and outgrowth stageof prostatic development was assessed by organ culture of embryonic
UGS from Wnt5a−/− mice removed prior to in vivo bud initiation at
e16.5. After 4 days of ex vivo culture, Wnt5a−/− UGS exhibited large
bulbous outgrowths intermingled with stunted buds projecting in a
random manner which sharply contrasted with the evenly spaced
protruding prostate buds of equivalent width in wild-type mice. Thus
while Wnt5a is not essential for prostate bud initiation, it is required
for proper bud position at regular intervals, regulation of bud size and
movement of cells along the proximal-to-distal axis.
Ex vivo cultures of newborn rat prostates found that exogenous
Wnt5a protein was capable of inhibiting epithelial cell proliferation
at the leading edge of outgrowing ducts resulting in marked
suppression of ductal outgrowth and branch point formation. It is
noteworthy that while total tip number was signiﬁcantly reduced by
the exogenous Wnt5a, the proportion of distal tip bifeds, trifeds and
lateral branching events was unaffected. Together these ﬁndings
suggest that secreted Wnt5a has a growth and branch point
suppressive function at the ductal tips as well along lateral surfaces
in the central–distal regions during active branching morphogenesis.
Previous studies from our laboratory and others have shown
important roles for Fgf10 in stimulating ductal outgrowth (Donjacour
et al., 2003; Huang et al., 2005), Shh in inhibiting distal tip growth at
speciﬁc sites during branch point formation (Pu et al., 2004), and
Bmp4 in suppressing bud and duct outgrowth (Lamm et al., 2001;
Prins et al., 2006). We propose that Wnt5a contributes to this
regulatory network that both stimulates and inhibits growth at
speciﬁc sites to regulate coordinate outgrowth and branch point
formation at regular intervals along the proximal–distal axis resulting
in a unique branch pattern during glandular morphogenesis.
While similar roles for Wnt5a have been reported in other
branched structures, there are also notable tissue speciﬁc differences.
The lungs of Wnt5a−/− mice exhibit truncation of the trachea and
overexpansion of the distal airways (Li et al., 2002) which bears
similarity to the cultured UGS/prostate complex with inhibition of
bud elongation and overexpansion into large bulbous structures.
While renal grafts of embryonicWnt5a−/− female reproductive tracts
were capable of forming a uterine compartment, they failed to
Fig. 9. Effects of neonatal estradiol exposure on prostatic expression ofWnt5a in the separate rat prostate lobes. (A) Real-time RT-PCR ofWnt5a mRNA levels over time in the VP, DP
and LP of rats exposed to oil or 25 μg estradiol benzoate on pnd 0, 2 and 4. Estrogen exposure resulted in a signiﬁcant and sustained increase in prostatic Wnt5a expression. Bars
represent the mean±SEM of 3–10 tissues at each time point. ⁎Pb0.05, ⁎⁎Pb0.01, ⁎⁎⁎Pb0.001, Oil vs. E2. (B) wmISH ofWnt5a mRNA in the pnd 3 prostatic complex of rats exposed to
oil (left) or estradiol (right) on pnd 0 and 2. Tissues were processed together to permit direct comparison of signal intensity. Photos are representatives of six separate sets of tissues.
Scale bar=200 μM. (C) Immunohistochemistry of Wnt5a protein in pnd 5 VPs of rats treated with oil (left) or estradiol (right) on pnd 0, 2 and 4. Photos are taken from tissues
sections mounted on a single glass slide to permit direct comparisons.Wnt5a signal is observed in periductal mesenchyme (arrows) and epithelial cells in the distal ducts of control
prostates and is weaker in the proximal region (arrowhead). In contrast, Wnt5a protein immunostain is increased in neonatal estradiol-exposed prostates with strong periductal
signal observed in the distal (arrow) as well as proximal lobes (arrowhead). Scale bar=100 μm.
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case for grafted Wnt5a−/− prostates in the present study. In the
mammary gland, exogenousWnt5a protein inhibited ductal extension
and lateral branching speciﬁcally (Roarty and Serra, 2007) which
differs from the prostate where branch inhibitionwas observed at the
distal tips as well as at lateral sites. It is possible that differences in
Wnt5a action across tissues may be a function of interactions with
other genes in an organ-speciﬁc manner.
Role of Wnt5a in epithelial cell differentiation, polarity and lumen
formation within prostatic ducts
In the present studies, delayed differentiation of epithelial and
mesenchymal cells and altered epithelial polarity were observed in rat
ex vivo VP cultures exposed to exogenous Wnt5a suggesting that
Wnt5a may play a role in suppressing cell differentiation. However,
prostates from null mutant Wnt5a−/− mice grafted under the renal
capsule showed full differentiation of mesenchyme to stromal cells
and epithelium to basal cells and secretory luminal cells indicatingthat Wnt5a is not essential for cyto- and functional differentiation of
the prostate gland. Similar ﬁndings were noted in Wnt5a−/− lungs
where differentiation of specialized cells was unaffected by loss of this
protein (Li et al., 2002). It is noteworthy that postnatal rescue of
Wnt5a−/− mouse mammary glands through renal grafts for 1 week
resulted in accelerated mammary development (Roarty and Serra,
2007). Since prostatic renal grafts were assessed after 4 weeks in the
present studies, we could not determine whether differentiation was
accelerated. However, the delayed prostate cell maturation in rat VP
organ cultures with exogenous Wnt5a concurs with the mammary
results. Since prostatic cell differentiation is temporally coordinated
with ductal outgrowth during morphogenesis, we postulate that the
observed shifts in glandular maturation with perturbed Wnt5a levels
are a function of altered growth rates of prostatic ducts rather than
direct effects on cell differentiation pathways.
Despite complete epithelial cytodifferentiation in renal grafted
Wnt5a−/− prostates, the ducts consistently exhibited defective and
incomplete lumenization with apparent loss of luminal cell polarity
and appropriate alignment. Noncanonical Wnt genes affect or control
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structures that include planar cell polarity and convergent extension
(Veeman et al., 2003). Wnt5a has been shown to function in planar
cell polarity of hair cells in the inner ear cochlea, a process essential for
proper cell alignment and orientation of stereocilia (Qian et al., 2007).
Most recently, Wnt5a was found to enhance cell polarization in
dispersed melanoma cells through the recruitment of actin, myosin
IIB, Frz3 and adhesion molecules into an intracellular structure
referred to as W-RAMP (Witze et al., 2008). This structure was
shown to distribute in a polarized manner, direct membrane
retraction and inﬂuence direction of cell movement. In this manner,
Wnt5a was demonstrated to control cell polarity and directional
movement in response to positional clues from chemical gradients. In
light of these ﬁndings, it is reasonable to suggest thatWnt5a may play
an essential role in directing prostate luminal cell polarity and
appropriate lumen formation.
Cross-regulation of Wnt5a with other morphoregulatory genes in the
signaling network that dictates prostate gland development
A gene regulatory network exists within the developing prostate
gland that organizes normal prostate development through a
temporal series of reciprocal signals and feedback loops (Prins and
Putz, 2008). Previous studies with Wnt5a−/− null mutant lungs
determined that expression of Shh, ptc, Fgf10 and Bmp4 was increased
in the absence of Wnt5a (Li et al., 2002) whereas targeted Wnt5a
overexpression in lung epithelium resulted in down-regulation of Shh
and ptc expression (Li et al., 2005). Further, direct down-regulation of
Shh expression by Wnt5a was demonstrated in lung carcinoma A549
cells cotransfected with Shh promoter reporter andWnt5a expression
constructs (Li et al., 2005). Results from the present study demon-
strate that Wnt5a is involved in the prostatic cross-regulatory gene
network, most notably through down-regulation regulation of Shh
and reciprocal up-regulation ofWnt5a by Shh to form a negative feed-
back loop. This is noteworthy since our previous studies showed
highly localized differences in Shh expression in distal tip epithelium
leading to focal changes in Fgf10 and Bmp4 gene expression and cell
proliferation (Huang et al., 2005). It was proposed that these localized
shifts in gene expression directly lead to branch point formation in
outgrowing prostatic ducts.We herein suggest thatWnt5amodulation
of Shh expression may contribute to this signaling network that
permits branching morphogenesis to proceed in an organized manner
in the developing prostate gland. Interestingly, cross regulation
between Wnt5a and Shh was observed in a lobe-speciﬁc manner
since short-term culture with Shh protein increasedWnt5a expression
in rat LP but not VP cultures. The separate prostate lobes have
distinctive branching patterns (Hayashi et al., 1991) and it is intriguing
to speculate that this may be a function of differential temporal
expression of Wnt5a and cross-regulation of key morphoregulatory
genes that dictate branching morphogenesis.
While there was no evidence for modulation byWnt5a of anyWnt
morphogens expressed during prostate development or for auto-
regulation of Wnt5a expression, Wnt5a protein markedly decreased
prostatic expression ofWif1 in the neonatal rat prostate. This suggests
that in addition to activation of its own downstream signaling
pathway, Wnt5a can modulate noncanonical and canonical Wnt
signaling through downregulation of this secreted Wnt inhibitor.
Hormone regulation of Wnt5a in the prostate gland
Hormone regulation of Wnt5a expression throughout the body
appears to be organ speciﬁc. Wnt5a expression is not regulated by
estrogen or progesterone in the mammary gland (Humphreys et al.,
1997; Weber-Hall et al., 1994) whereas it is up-regulated in the uterus
after neonatal exposure to the potent synthetic estrogen, diethyl-
stilbestrol (DES) (Couse et al., 2001; Mericskay et al., 2004). Theselater results are similar to those of the present study where estradiol
permanently up-regulatesWnt5a expression in the prostate. Interest-
ingly, the uterine Wnt5a response to DES was not dependent on ERα
since its expression increased in ERα knock out mice treated with DES
(Couse et al., 2001). While the requirement of stromal ERα forWnt5a
up-regulation by estradiol was not directly examined in the present
study, we have previously shown that neonatal estrogen's phenotypic
effects on the prostate require ERα (Prins et al., 2001). Although a
genomic screen identiﬁed estrogen response elements in the
promoters of Wnt2b, 4 and 10b (Bourdeau et al., 2004), they were
not identiﬁed in the Wnt5a promoter thus it is possible that estrogen
actions on Wnt5a expression are not direct. In the mammary gland,
Wnt5a is up-regulated by Tgfβ (Roarty and Serra, 2007). Since we
have previously shown that neonatal estradiol up-regulates Tgfβ1 levels
inprostatic periductal stromal cells (Changet al.,1999), it is possible that
estradiol effects on prostatic Wnt5a are indirectly mediated through
elevated Tgfβ1. Similar to our previous report (Pu et al., 2007),
testosterone exposure during early prostate development suppressed
Wnt5a expressionwhich supports the hypothesis that down-regulation
of growth inhibitory factors by androgens contributes to global prostate
morphogenesis. Retinoic acid has also been shown to directly regulate
Wnt gene expression and signaling in a variety of developing
mammalian organs (Chen et al., 2002; Kudoh et al., 2002) indicating
that steroidal regulation of Wnt gene expression is widespread. Since
thedevelopingprostate expressesRARs, RXRs and retinoidmetabolizing
enzymes (Prins et al., 2002), it is possible that retinoids may also be
involved in regulation of prostaticWnt5a expression.
In summary, the present studies establish a role for Wnt5a during
prostate gland development. Wnt5a is involved in initial bud
positioning, regulation of ductal outgrowth along the proximal–distal
axis, branchpoint formation, luminal cell polarity and lumen forma-
tionwithin the prostatic ducts. Evidence suggests thatWnt5a interacts
with other morphoregulatory genes in a complex signaling network to
tightly control branching morphogenesis and glandular maturation.
Expression of Wnt5a is modulated by steroids during prostate
development including testosterone and estradiol that suppress and
stimulate expression, respectively. This is of particular importance
since aberrant expression ofWNT5a has been shown in several human
malignancies, including elevated expression in prostate carcinomas
(Iozzo et al., 1995). These ﬁndings add to the growing body of
knowledge of the regulatory mechanisms involved in prostate
development which are key to understanding abnormal growth
regulation associated with prostate cancer.
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